ondansetron has been researched along with 1-(3-chlorophenyl)piperazine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Borsini, F; D'Aranno, V; Lecci, A; Mancinelli, A; Meli, A; Stasi, MA; Volterra, G | 1 |
| Bill, DJ; Dourish, CT; Fletcher, A; Grewal, SS; Shepherd, JK | 1 |
| Fiorella, D; Helsley, S; Rabin, RA; Winter, JC | 1 |
| Baldemore, D; Briggs, NC; Broocks, A; Canter, SK; Hill, JL; Murphy, DL; Pigott, TA; Tolliver, TJ | 1 |
| Broocks, A; Dubbert, B; Little, JT; Mack, C; Martin, A; Minichiello, MD; Murphy, DL; Sunderland, T; Tune, L | 1 |
| Broocks, A; Canter, S; Grady, TA; Hill, JL; L'Heureux, F; Murphy, DL; Pigott, TA | 1 |
| Furuichi, K; Miyake, A; Mochizuki, S; Saito, M; Watanabe, T | 1 |
| Baptista-de-Souza, D; Canto-de-Souza, A; Canto-de-Souza, L; de Souza, RR; Lopes, LT; Nunes-de-Souza, RL | 1 |
3 trial(s) available for ondansetron and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.
Topics: Adult; Anxiety; Behavior; Blood Pressure; Body Temperature; Euphoria; Female; Heart Rate; Humans; Injections, Intravenous; Male; Neurosecretory Systems; Ondansetron; Piperazines; Self-Assessment; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.
Topics: Adult; Behavior; Cognition; Female; Humans; Male; Memory; Ondansetron; Parasympatholytics; Piperazines; Psychomotor Performance; Pupil; Reaction Time; Reference Values; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |
Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.
Topics: Adult; Analysis of Variance; Behavioral Symptoms; Double-Blind Method; Drug Interactions; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neurosecretory Systems; Obsessive-Compulsive Disorder; Ondansetron; Piperazines; Psychiatric Status Rating Scales; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 1998 |
7 other study(ies) available for ondansetron and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Body Temperature Regulation; Buspirone; Diazepam; Ergolines; Fenclonine; Fever; Flumazenil; Imidazoles; Male; Mice; Ondansetron; Piperazines; Piperidines; Ritanserin; Serotonin; Serotonin Antagonists; Stress, Psychological; Tetrahydronaphthalenes | 1990 |
Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Ondansetron; Piperazines; Posture; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1994 |
5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
Topics: Animals; Choroid Plexus; Conditioning, Operant; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug Interactions; Ketanserin; Lysergic Acid Diethylamide; Ondansetron; Phosphatidylinositols; Piperazines; Pyrazines; Quipazine; Rats; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |
Cloning, expression, and characterization of ferret 5-HT(3) receptor subunit.
Topics: Alternative Splicing; Amino Acid Sequence; Animals; Biguanides; Binding, Competitive; Cell Line; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; Ferrets; Gene Expression; Humans; Imidazoles; Indoles; Kruppel-Like Factor 6; Kruppel-Like Transcription Factors; Membrane Potentials; Molecular Sequence Data; Ondansetron; Piperazines; Proto-Oncogene Proteins; Radioligand Assay; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; RNA, Messenger; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tissue Distribution; Trans-Activators; Tritium; Tubocurarine | 2000 |
The interplay between 5-HT
Topics: Animals; Anxiety; Behavior, Animal; Biguanides; Male; Mice; Ondansetron; Periaqueductal Gray; Piperazines; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin, 5-HT3; Serotonin | 2022 |